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Available online 23 February 2016The human embryonic stem cell line RCe012-A (RC-8) was derived from a frozen and thawed day 5 embryo cul-
tivated to the blastocyst stage. The embryowas voluntarily donated as unsuitable and surplus to fertility require-
ments following ethics committee approved informed consent under licence from the UK Human Fertilisation
and Embryology Authority. The cell line shows normal pluripotency marker expression and differentiation to
the three germ layers in vitro. It has a normal 46XX female karyotype and microsatellite PCR identity, HLA and
blood group typing data is available.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
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RCe012-A (RC-8) was derived from a thawed day 5 blastocyst that
was surplus to requirement or unsuitable for clinical use. The cell lineEdinburgh Bio-Quarter, 9 Little
. This is an open access article underwas derived by whole embryo outgrowth on mitotically inactivated
human ﬁbroblast (HDF) feeder cells using xeno-free medium (XF
KODMEM) and expanded under xeno free and feeder free conditions.
By ﬂow cytometry, RCe012-A (RC-8) expressed the pluripotency
makers Oct-4, Tra-1-60 and SSEA-4 (94.7%, 89.4% and 99.8%, respective-
ly), whereas low expression of the differentiationmarker SSEA-1 (2.2%)
was observed (Fig. 1, Table 1). Differentiation to the three germ layers,
endoderm, ectoderm and mesoderm, was demonstrated using embry-
oid body formation and expression of the germ layer markers α-
fetoprotein, β-tubulin and muscle actin (Fig. 2).
A microsatellite PCR proﬁle has been obtained for the cell line, and
HLA Class I and II typing is available (Table 2). Blood group genotyping
gave the blood group AO1 (Table 2).
Veriﬁcation and authentication
The cell line was analysed for genome stability by G-banding (Fig. 3)
and showed a normal 46XX female genotype. The cell line is free from
mycoplasma contamination as determined by RC-qPCR. Microsatellite
PCR DNA proﬁling for cell identity is available (Table 2).
Materials and methods
Ethics
Derivation of hESC from surplus to requirement and failed to
fertilise/develop embryos was approved by The Scotland A Research
Ethics Committee and local ethics board at participating fertility clinics
and conducted under licence no R0136 from the UK HFEA with in-
formed donor consent.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. RCe012-A (RC-8) was subjected to ﬂow cytometry analysis for markers of pluripotency with speciﬁc antibody (top row) or isotype control (bottom row) as indicated above the
histograms. Percentage staining is indicated in Table 1.
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Vitriﬁed embryos were thawed using Vitriﬁed Embryo Safety
Thawing Pack (Kitazato/Dibimed, Valencia, Spain) according toman-
ufacturers' instruction and were cultured in system SAGE Quinn's
Advanced Blastocyst medium (Rochford Medical, Coventry) after
day 3 of development. Embryos were cultured at 36.5–37.5 °C, 5 ±
0.5% CO2, 5 ± 0.5% O2 in drops under parafﬁn oil (Rochford Medical)
and transferred to fresh medium at least every 2–3 days.
By day 8 of development, embryos were placed in derivation condi-
tions consisting ofmitotically inactivated neonatal human dermal ﬁbro-
blasts (HDFs) (ThermoFisher Scientiﬁc (Cascade Biologics), Paisley, UK)
on tissue culture plastic in XF KODMEM medium (Knockout-DMEM,
15% KOSR-XF, 2 mM L-glutamine, 1% MEM Non-essential amino acids,
2% XF Growth Factor Cocktail, 0.1 mM β-mercaptoethanol, all
ThermoFisher Scientiﬁc, Paisley, UK) supplemented with 80 ng/ml
human bFGF (ThermoFisher Scientiﬁc). Assisted hatching was per-
formed by removing the zona pellucidae mechanically using Swemed
Cutting tools (Vitrolife, Göteborg, Sweden).
HDF cells were cultured in DMEM (Lonza, Slough, UK), 10% FCS (GE
Healthcare (PAA), Buckinghamshire, UK) and 2 mM L-glutamine
(ThermoFisher Scientiﬁc). HDFs were mitotically inactivated using
gamma irradiation at 50GY using a Gammacell Elite 1000 machine.
For use as a feeder layer, irradiated HDFs were plated at 50,000 cells/
cm2 in XF KODMEM medium supplemented with 80 ng/ml humanTable 1
Summary of quality control testing and results for RCe012-A (RC-8).
Classiﬁcation
Test Purpose
Donor screening HIV 1 + 2
Hepatitis B
Hepatitis C
Donor screenin
Identity Microsatellite PCR (mPCR) DNA proﬁling
gender/species
Phenotype Flow cytometry Assess antigen
commonly ass
Genotype
(details provided in Table 2)
Blood group genotyping
(DNA analysis)
To establish bl
Karyology (G-banding) Conﬁrmation o
HLA tissue typing To establish fu
Microbiology and virology Mycoplasma Mycoplasma te
Endotoxin Screening for e
Morphology Photography To capture a vi
Differentiation potential Embryoid body formation To show differbFGF (ThermoFisher Scientiﬁc). Cells were cultured at 36.5–37.5 °C,
5 ± 0.5% CO2, 5 ± 0.5% O2 and 50% medium exchanged 6 days a week.
The established cell line was expanded and banked using CellStart
matrix and Stempro hESC Serum Free Medium (ThermoFisher Scientif-
ic). Passaging was performed mechanically using an EZ passage tool
(ThermoFisher Scientiﬁc). hESC lines were expanded to 25–30 wells of
a 6-well plate and cryopreserved in 0.5-1 ml Cryostor CS10 (Biolife So-
lution, Washington, USA).
Mycoplasma
Mycoplasma detection was performed using Applied Biosystems
PrepSEQ™ Mycoplasma Nucleic Acid Extraction Kit and MicroSEQ™
MycoplasmaReal-Time PCRDetection Kit (ThermoFisher Scientiﬁc (Ap-
plied Biosystems)) according to manufacturer's instruction.
Endotoxin
Endotoxin levels were determined using the Kinetic-QCL assay
(Lonza) and an incubating plate reader (BioTek ELx808) according to
manufacturer's instructions. Brieﬂy, an unknown samplewas compared
with a standard curve of known levels of control endotoxin. An assay
was deemed valid if the coefﬁcient of correlation, r ≥ 0.980 and the CV
(%) for the standard curve was ≤10%.Result
g for adventitious agents Negative
to give cell line its signature, Performed
levels & cell surface markers
ociated with hESC
Oct 3/4: 94.7%
Tra 1-60: 89.4%
SSEA-4: 99.8%
SSEA-1: 2.2%
ood group of the line O1O1
f normal ploidy by G-banding 46XX
ll HLA type I and II genotype of the line HLA typed class I and class II
sting by RT-qPCR Negative
ndotoxin levels 0.54 EU/ml
sual record of the line Normal
entiation to three germ layers Expression of muscle actin, β-tubulin
and α-feto protein
Fig. 2. In vitro differentiation of RCe012-A (RC-8) to ectoderm (β-tubulin III), mesoderm (muscle actin), and endoderm (α-fetoprotein). Speciﬁc staining shown in green, cell nuclei are
counterstained with DAPI (blue). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Pluripotency was determined using the Human andMouse Pluripo-
tent StemCell Analysis kit (BD,Oxford, UK). Oct 3/4 and SSEA-4were in-
cluded as pluripotencymarkers, and SSEA-1 as a differentiationmarker.
FITC conjugated Tra-1-60 (BD) was used as an additional pluripotency
marker. Fixed and permeabilised cells were analysed using a FACS
Aria ﬂow cytometer (BD). Percentage expression of each marker was
compared to isotype control or unstained cells.
Immunocytochemistry
hESC were ﬁxed in methanol (ThermoFisher Scientiﬁc), blocked using
10% goat serum (Sigma-Aldrich, Dorset, UK) in PBS (Lonza) containing
0.01% Tween-20 (Sigma) and stained with AFP (1:500; Sigma), β-
tubulin III (1:1000; Sigma), muscle-speciﬁc actin (1:50; DAKO, Glostrup,
Denmark), and secondary antibody anti-goat IgG-AlexaFluor 488 (1:200;
ThermoFisher Scientiﬁc). Images were acquired using a Zeiss S100
Axiovert ﬂuorescence microscope or Nikon eC1 confocal microscope.
In vitro differentiation
Conﬂuent hESC cells lifted using a cell scraper (Corning) and embry-
oid bodies EBs generated in ultra low attachment plates (Corning) in EB
medium (20% FBS (GE Healthcare (PAA)), 80% KO-DMEM 1mM L-gluta-
mine, 0.1 mM β-mercaptoethanol, 1% nonessential amino acids (all
ThermoFisher Scientiﬁc)). After 9 days in suspension culture, EBs were
being transferred onto glass slide tissue culture chambers (Nunc,
ThermoFisher Scientiﬁc) coated with 0.1% gelatin (Sigma) at 0.1 ml/cm2
and cultured for 14 days.Table 2
Microsatellite PCR, blood group and HLA tissue typing results for RCe012-A (RC-8).
Microsatellite PCR results
D3S1358 1 D3S1358 2 vWA 1 vWA 2
14 16 17 19
Amelogenin 1 Amelogenin 2 D8S1179 1 D8S1179 2
X X 14 16
D19S433 1 D19S433 2 THO1 1 THO1 2
14 14 7 9.3
D5S818 1 D5S818 2 D7S820 1 D7S820 2
9 11 8 10
Blood group genotyping
RhD RhC Rhc RhE
pos pos neg neg
Jka Jkb K k
neg pos neg pos
Kp a Kp b Do a Do b
neg pos pos pos
HLA tissue typing
HLA class I type HLA-A*02, A*32; B*15, B*38; C*03, C*1
HLA class II type HLA-DRB1*04, DRB1*15; DRB4*01; DR
Comment C*03 is expressed serologically as C10,
serologically as B62, DQB1*03 is expreGenomic analysis
All outsourced assays were carried out under a Quality and Tech-
nical Agreement. DNA was extracted using the QIAamp DNAMini kit
(Qiagen, Manchester, UK) according to manufacturer's recommen-
dations and provided in recommended quantities to the service
providers.
Microsatellite PCR, or Short Tandem Repeat analysis, was used to
determine cell line identity and was carried out by Public Health En-
gland. A proﬁle was obtained for the following core alleles: vWA,
D16S539, Amelogenin, THO1, CSF1PO, D5S818, D75820, D135317
and TPOX.
Human Leukocyte Antigen (HLA) tissue typing was carried out by
the Scottish National Blood Transfusion Service.
Blood group genotyping was carried out by the Molecular Diagnos-
tics laboratory at NHSBT.
Karyotype analysis was carried out by The Doctors Laboratory
(London, UK) or the Western General Cytogenetics Laboratory (Edin-
burgh, UK) Live cells at 60–70% conﬂuency were shipped overnight in
warm containers, ﬁxed and analysed by standard G-banding analysis.
For research grade lines, 20 spreads were analysed.Acknowledgements
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Fig. 3. RCe012-A (RC-8) was analysed by Giesma staining of 20 metaphase spreads at passage 23 and showed a normal 46XX female karyotype in 17 of 20 spreads. Abnormalities in the
three remaining cells are believed to be results of harvesting artefacts. An independent assessment of karyology on the same cell line at passage 54 indicated normal 46XX karyology all 20
cells examined.
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